Latest News
FDA/CDC
Endo removes Opana ER from market
The move is in compliance with an FDA request citing a spike in abuse of the opioid agonist.
Latest News
New on the streets: Drug for nerve pain boosts high for opioid abusers
ATHENS, OHIO – On April 5, Ciera Smith sat in a car parked on the gravel driveway of the Rural Women’s Recovery Program here with a choice to make...
Conference Coverage
Do sleep interventions prevent atrial fibrillation?
WASHINGTON – Obstructive sleep apnea treatment may not fend off arrhythmias in patients with cardiovascular disease.
From the Journals
Cognitive declines tied to stress in older African Americans
Watch for more rapid declines in episodic memory and visuospatial ability in African Americans aged 65 years and older who report high levels of...
From the Journals
Herpes zoster raises risk of stroke, MI
Several mechanisms of action are offered.
News from the FDA/CDC
‘Chronic Lyme’: Serious bacterial infections reported with unproven treatments
Five case reports illustrate the dangers of unproven treatments for so-called chronic Lyme disease.
Conference Coverage
Gene therapy for spinal muscular atrophy shows promise in early study
BOSTON – Early data show remarkable results for a gene therapy with few adverse events, in a phase I study.
Conference Coverage
TB meningitis cases in U.S. are fewer but more complicated
BOSTON – Seizures and strokes have risen in hospitalized TB meningitis patients.
Conference Coverage
English infant quadravalent group B meningococcal vaccine pays off
MADRID – Invasive meningococcal disease cases are dropping.
Feature
Health IT: Cybercrime risks are real
Feds offer six-point plan for increasing cybersecurity in medicine
Feature
Malpractice reform: House passes bill to cap damages
Doctors, malpractice insurers back the legislation.